{
  "trial_id": "NCT00005879",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Sex, Menopausal status, Hemoglobin level, Granulocyte count, Protein C level, Protein S level, Antithrombin III level, Activated protein C resistance, Albumin level, Bilirubin level, AST level, Alkaline phosphatase level, Creatinine level, History of deep venous thrombosis, History of coronary artery disease, History of stroke, Pregnancy status, Use of contraception, History of other active cancer, History of retinal vein thrombosis, History of severe poorly controlled migraine, Factor V Leiden mutation status, Prior immunotherapy, Prior chemotherapy, Prior hormone replacement therapy, Prior oral contraceptive use, Prior tamoxifen use, Prior raloxifene use, Prior antihormonal therapy, Prior radiotherapy, Prior oophorectomy, Use of other new medication.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex"
        ],
        [
          "Menopause Status",
          "Menopausal status"
        ],
        [
          "Hormone Use",
          "Prior hormone replacement therapy"
        ],
        [
          "Prior Biopsy",
          "Prior chemotherapy"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Height",
        "Weight",
        "BMI",
        "Age at Menarche",
        "Age at First Live Birth",
        "Number relatives with Breast Cancer"
      ],
      "remaining_candidate_features": [
        "Hemoglobin level",
        "Granulocyte count",
        "Protein C level",
        "Protein S level",
        "Antithrombin III level",
        "Activated protein C resistance",
        "Albumin level",
        "Bilirubin level",
        "AST level",
        "Alkaline phosphatase level",
        "Creatinine level",
        "History of deep venous thrombosis",
        "History of coronary artery disease",
        "History of stroke",
        "Pregnancy status",
        "Use of contraception",
        "History of other active cancer",
        "History of retinal vein thrombosis",
        "History of severe poorly controlled migraine",
        "Factor V Leiden mutation status",
        "Prior immunotherapy",
        "Prior oral contraceptive use",
        "Prior tamoxifen use",
        "Prior raloxifene use",
        "Prior antihormonal therapy",
        "Prior radiotherapy",
        "Prior oophorectomy",
        "Use of other new medication"
      ]
    },
    "processed-gen-response": "Age, Sex, Menopausal status, Hemoglobin level, Granulocyte count, Protein C level, Protein S level, Antithrombin III level, Activated protein C resistance, Albumin level, Bilirubin level, AST level, Alkaline phosphatase level, Creatinine level, History of deep venous thrombosis, History of coronary artery disease, History of stroke, Pregnancy status, Use of contraception, History of other active cancer, History of retinal vein thrombosis, History of severe poorly controlled migraine, Factor V Leiden mutation status, Prior immunotherapy, Prior chemotherapy, Prior hormone replacement therapy, Prior oral contraceptive use, Prior tamoxifen use, Prior raloxifene use, Prior antihormonal therapy, Prior radiotherapy, Prior oophorectomy, Use of other new medication."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Menopausal status, Hemoglobin, Granulocyte count, Albumin, Bilirubin, AST, Alkaline phosphatase, Creatinine, History of deep venous thrombosis, History of coronary artery disease, History of stroke, Hormone replacement therapy use, Oral contraceptive use, Prior chemotherapy, Prior radiotherapy, Prior surgery, Genetic counseling and testing for BRCA1 and BRCA2, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Menopausal status"
        ],
        [
          "Menopause Status",
          "Menopausal status"
        ],
        [
          "Hormone Use",
          "Hormone replacement therapy use"
        ],
        [
          "Hormone Use",
          "Oral contraceptive use"
        ],
        [
          "Prior Biopsy",
          "Genetic counseling and testing for BRCA1 and BRCA2"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Height",
        "Weight",
        "BMI",
        "Age at Menarche",
        "Age at First Live Birth",
        "Number relatives with Breast Cancer"
      ],
      "remaining_candidate_features": [
        "Hemoglobin",
        "Granulocyte count",
        "Albumin",
        "Bilirubin",
        "AST",
        "Alkaline phosphatase",
        "Creatinine",
        "History of deep venous thrombosis",
        "History of coronary artery disease",
        "History of stroke",
        "Prior chemotherapy",
        "Prior radiotherapy",
        "Prior surgery"
      ]
    },
    "processed-gen-response": "Age, Menopausal status, Hemoglobin, Granulocyte count, Albumin, Bilirubin, AST, Alkaline phosphatase, Creatinine, History of deep venous thrombosis, History of coronary artery disease, History of stroke, Hormone replacement therapy use, Oral contraceptive use, Prior chemotherapy, Prior radiotherapy, Prior surgery, Genetic counseling and testing for BRCA1 and BRCA2"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Menopausal Status, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Gail Risk Score, BRCAPRO Risk Score, BRCA1/2 Mutation Status, History of Contralateral Ductal Carcinoma In Situ or Invasive Breast Cancer, ACR Class, Endometrial Thickening, Hemoglobin, Granulocyte Count, Albumin, Bilirubin, AST, Alkaline Phosphatase, Creatinine.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Menopause Status",
          "Menopausal Status"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "BMI",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Height",
        "Weight",
        "Hormone Use",
        "Age at Menarche",
        "Age at First Live Birth",
        "Prior Biopsy",
        "Number relatives with Breast Cancer"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Gail Risk Score",
        "BRCAPRO Risk Score",
        "BRCA1/2 Mutation Status",
        "History of Contralateral Ductal Carcinoma In Situ or Invasive Breast Cancer",
        "ACR Class",
        "Endometrial Thickening",
        "Hemoglobin",
        "Granulocyte Count",
        "Albumin",
        "Bilirubin",
        "AST",
        "Alkaline Phosphatase",
        "Creatinine"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Menopausal Status, Race/Ethnicity, Region of Enrollment, Body Mass Index, Gail Risk Score, BRCAPRO Risk Score, BRCA1/2 Mutation Status, History of Contralateral Ductal Carcinoma In Situ or Invasive Breast Cancer, ACR Class, Endometrial Thickening, Hemoglobin, Granulocyte Count, Albumin, Bilirubin, AST, Alkaline Phosphatase, Creatinine."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, menopausal status, race, ethnicity, body mass index (BMI), smoking status, family history of breast cancer, Gail risk score, BRCAPRO risk score, BRCA1/2 mutation status, history of contralateral ductal carcinoma in situ or invasive breast cancer, ACR class on mammogram, endometrial thickening, hemoglobin, granulocyte count, albumin, bilirubin, AST, alkaline phosphatase, creatinine, history of deep venous thrombosis, history of coronary artery disease, history of stroke, history of retinal vein thrombosis, history of migraine, factor V Leiden mutation carrier status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Menopause Status",
          "menopausal status"
        ],
        [
          "BMI",
          "body mass index (BMI)"
        ],
        [
          "Number relatives with Breast Cancer",
          "family history of breast cancer"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Height",
        "Weight",
        "Hormone Use",
        "Age at Menarche",
        "Age at First Live Birth",
        "Prior Biopsy"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "smoking status",
        "Gail risk score",
        "BRCAPRO risk score",
        "BRCA1/2 mutation status",
        "history of contralateral ductal carcinoma in situ or invasive breast cancer",
        "ACR class on mammogram",
        "endometrial thickening",
        "hemoglobin",
        "granulocyte count",
        "albumin",
        "bilirubin",
        "AST",
        "alkaline phosphatase",
        "creatinine",
        "history of deep venous thrombosis",
        "history of coronary artery disease",
        "history of stroke",
        "history of retinal vein thrombosis",
        "history of migraine",
        "factor V Leiden mutation carrier status"
      ]
    },
    "processed-gen-response": "Age, sex, menopausal status, race, ethnicity, body mass index (BMI), smoking status, family history of breast cancer, Gail risk score, BRCAPRO risk score, BRCA1/2 mutation status, history of contralateral ductal carcinoma in situ or invasive breast cancer, ACR class on mammogram, endometrial thickening, hemoglobin, granulocyte count, albumin, bilirubin, AST, alkaline phosphatase, creatinine, history of deep venous thrombosis, history of coronary artery disease, history of stroke, history of retinal vein thrombosis, history of migraine, factor V Leiden mutation carrier status."
  }
}